Delivery Order SPE2DB24D2205-SPE2DB25FEHKK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg on July 28, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ofev (nintedanib) is a specialized pharmaceutical used primarily in the treatment of pulmonary fibrosis and other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- On September 2, 2025, the Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg. This non-competitive, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. Ofev (nintedanib) is a prescription medication used in the treatment of certain pulmonary conditions, reflecting the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $8,590.58 and an ultimate completion date of August 8, 2025. The contract was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $17,181.16 to AmerisourceBergen Drug Corp for Ofev 150 mg capsules (60-count units) on August 14, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026. The place of performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg on July 25, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be performed from the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in a 60-count unit, with a contract ceiling value of $17,260.58. This firm fixed price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 24, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units, valued at $8,590.58. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and was awarded on August 22, 2025, without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of OFEV 150 mg capsules (60-count units) under a firm fixed-price contract with a ceiling value of $8,590.58. This non-competitive set-aside delivery order is scheduled for completion by September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. OFEV (nintedanib) is a specialized pharmaceutical product used...
- The Defense Logistics Agency awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on August 18, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. OFEV (nintedanib) is a specialty pharmaceutical used in the treatment of pulmonary fibrosis...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHKKDelivery Order
The Defense Logistics Agency awarded a $51,543.48 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed price delivery order with an ultimate completion date of October 2, 2025, and represents a non-competitive set-aside award. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Ofev is a specialty pharmaceutical used primarily in the treatment of pulmonary fibrosis and other interstitial lung diseases, reflecting the Defense Logistics Agency's critical role in supplying specialized medications to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The Defense Logistics Agency is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, which positions AmerisourceBergen among the key vendors supporting the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.5k | 9/11/25 |